خط مشی دسترسیدرباره ما
ثبت نامثبت نام
راهنماراهنما
فارسی
ورودورود
صفحه اصلیصفحه اصلی
جستجوی مدارک
تمام متن
منابع دیجیتالی
رکورد قبلیرکورد بعدی
نوع مدرک : TF
زبان مدرک : فارسی
شماره رکورد : 66984
شماره مدرک : ‭پ۵۳۴۸۸‬
شماره راهنما : ‭ت۲۵۹۸‬
سر شناسه : ن‍ج‍ف‍ی‌، ع‍ل‍ی‌
عنوان اصلي : بررسی تاثیر تجویز سفوکتاکسیم در مقایسه با آمپی سیلین در مادران حامله دچار پارگی زودرس کیسه آب
نام عام مواد : [پایان‌نامه]
نام نخستين پديدآور : /علی نجفی
نام ساير پديدآوران : ؛استاد راهنما: حسن بسکابادی، نفیسه ثقفی
عنوان ديگر : عنوان به انگلیسی‭Assessment the maternal and neonatal complications of premature rupture of membrane after prophylactic adminstration of cefotaxime in pregnant woman compared with ampicilline :‬
وضعيت نشر : دانشگاه علوم پزشکی مشهد، ‭۱۳۹۱‬، دانشکده پزشکی
صفحه شمار : ‮‭[۷۷]‬ ص.‬: جدول، نمودار
يادداشت : چکیده فارسی، چکیده انگلیسی
يادداشت : چاپی
خلاصه يا چکيده : ‭Background:Premature rupture of membrane has remained as a problem.the most bacteries involved in PROM in women in iran are gram negatives .so ,we decided to use cefotaxim instead of ampicillin in treatment of PROM then assess its complications in neonates.Material and methods:180 pregnant women with PROM that need to antibiotics were participated in this clinical trial study. They were divided in two groups, randomly. Patients in control group were received ampicillin and case group received cefotaxime. Then apgar score, cardiopulmonary and neurological condition, infection, prematurity, asphyxia,clinical tests,discharge condition and mortality rate was compared between neonates of two groups by SPSS 14.5.Results:Duration of rupture of membrane was not different significantly between two groups (p=0.85). Neonates in the control group need to CPR more than the other one (p=0.003). The number of infants admitted to NICU, infection rate and asphyxia rate were higher in control group (p=0.003, p=0.038, p=0.003). Prematurity and respiratory distress syndrome showed no significant difference between two groups (p=0.06, p=0.062). Mortality rate in control group was 18.6 but no death was reported in case group.Conclusion:Cefotaxime is a good alternative treatment for ampicillin in PROM patients due to reduction in neonatal morbidities.‬
 
 
 
(در صورت عدم وضوح تصویر اینجا را کلیک نمایید)